2022-2027 Global and Regional Diphtheria, Pertussis, and Tetanus Vaccine Industry Status and Prospects Professional Market Research Report Standard Version
Date: Jan-2022 | Id: MACRC-74159 | Geographical Scope: Global | Publisher: Mnemonics Research
The global Diphtheria, Pertussis, and Tetanus Vaccine market was valued at 2491.79 Million USD in 2021 and will grow with a CAGR of 4.02% from 2021 to 2027, based on Mnemonics Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America). Diphtheria, pertussis, and tetanus (DPT) vaccine is administered for three infectious diseases in humans-diphtheria, tetanus, and pertussis. They are administered either in childhood or middle age to produce the acquired immunity against diphtheria, pertussis, and tetanus. By Market Verdors: Johnson & Johnson GlaxoSmithKline Sanofi Lanzhou Institute of Biological Merck Novartis AstraZeneca Emergent Astellas By Types: DTaP Td Tdap By Applications: Hospitals Clinics Vaccination Centers Key Indicators Analysed Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors. Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications. Market Trends: Market key trends which include Increased Competition and Continuous Innovations. Opportunities and <b>Drivers:</b> Identifying the Growing Demands and New Technology Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry. Key Reasons to Purchase To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape. Assess the production processes, major issues, and solutions to mitigate the development risk. To understand the most affecting driving and restraining forces in the market and its impact in the global market. Learn about the market strategies that are being adopted by leading respective organizations. To understand the future outlook and prospects for the market. Besides the standard structure reports, we also provide custom research according to specific requirements.
Chapter 1 Industry Overview 1.1 Definition 1.2 Assumptions 1.3 Research Scope 1.4 Market Analysis by Regions 1.4.1 North America Market States and Outlook (2022-2027) 1.4.2 East Asia Market States and Outlook (2022-2027) 1.4.3 Europe Market States and Outlook (2022-2027) 1.4.4 South Asia Market States and Outlook (2022-2027) 1.4.5 Southeast Asia Market States and Outlook (2022-2027) 1.4.6 Middle East Market States and Outlook (2022-2027) 1.4.7 Africa Market States and Outlook (2022-2027) 1.4.8 Oceania Market States and Outlook (2022-2027) 1.4.9 South America Market States and Outlook (2022-2027) 1.5 Global Diphtheria, Pertussis, and Tetanus Vaccine Market Size Analysis from 2022 to 2027 1.5.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Market Size Analysis from 2022 to 2027 by Consumption Volume 1.5.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Market Size Analysis from 2022 to 2027 by Value 1.5.3 Global Diphtheria, Pertussis, and Tetanus Vaccine Price Trends Analysis from 2022 to 2027 1.6 COVID-19 Outbreak: Diphtheria, Pertussis, and Tetanus Vaccine Industry Impact Chapter 2 Global Diphtheria, Pertussis, and Tetanus Vaccine Competition by Types, Applications, and Top Regions and Countries 2.1 Global Diphtheria, Pertussis, and Tetanus Vaccine (Volume and Value) by Type 2.1.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Consumption and Market Share by Type (2016-2021) 2.1.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue and Market Share by Type (2016-2021) 2.2 Global Diphtheria, Pertussis, and Tetanus Vaccine (Volume and Value) by Application 2.2.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Consumption and Market Share by Application (2016-2021) 2.2.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue and Market Share by Application (2016-2021) 2.3 Global Diphtheria, Pertussis, and Tetanus Vaccine (Volume and Value) by Regions 2.3.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Consumption and Market Share by Regions (2016-2021) 2.3.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue and Market Share by Regions (2016-2021) Chapter 3 Production Market Analysis 3.1 Global Production Market Analysis 3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis 3.1.2 2016-2021 Major Manufacturers Performance and Market Share 3.2 Regional Production Market Analysis 3.2.1 2016-2021 Regional Market Performance and Market Share 3.2.2 North America Market 3.2.3 East Asia Market 3.2.4 Europe Market 3.2.5 South Asia Market 3.2.6 Southeast Asia Market 3.2.7 Middle East Market 3.2.8 Africa Market 3.2.9 Oceania Market 3.2.10 South America Market 3.2.11 Rest of the World Market Chapter 4 Global Diphtheria, Pertussis, and Tetanus Vaccine Sales, Consumption, Export, Import by Regions (2016-2021) 4.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Consumption by Regions (2016-2021) 4.2 North America Diphtheria, Pertussis, and Tetanus Vaccine Sales, Consumption, Export, Import (2016-2021) 4.3 East Asia Diphtheria, Pertussis, and Tetanus Vaccine Sales, Consumption, Export, Import (2016-2021) 4.4 Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales, Consumption, Export, Import (2016-2021) 4.5 South Asia Diphtheria, Pertussis, and Tetanus Vaccine Sales, Consumption, Export, Import (2016-2021) 4.6 Southeast Asia Diphtheria, Pertussis, and Tetanus Vaccine Sales, Consumption, Export, Import (2016-2021) 4.7 Middle East Diphtheria, Pertussis, and Tetanus Vaccine Sales, Consumption, Export, Import (2016-2021) 4.8 Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales, Consumption, Export, Import (2016-2021) 4.9 Oceania Diphtheria, Pertussis, and Tetanus Vaccine Sales, Consumption, Export, Import (2016-2021) 4.10 South America Diphtheria, Pertussis, and Tetanus Vaccine Sales, Consumption, Export, Import (2016-2021) Chapter 5 North America Diphtheria, Pertussis, and Tetanus Vaccine Market Analysis 5.1 North America Diphtheria, Pertussis, and Tetanus Vaccine Consumption and Value Analysis 5.1.1 North America Diphtheria, Pertussis, and Tetanus Vaccine Market Under COVID-19 5.2 North America Diphtheria, Pertussis, and Tetanus Vaccine Consumption Volume by Types 5.3 North America Diphtheria, Pertussis, and Tetanus Vaccine Consumption Structure by Application 5.4 North America Diphtheria, Pertussis, and Tetanus Vaccine Consumption by Top Countries 5.4.1 United States Diphtheria, Pertussis, and Tetanus Vaccine Consumption Volume from 2016 to 2021 5.4.2 Canada Diphtheria, Pertussis, and Tetanus Vaccine Consumption Volume from 2016 to 2021 5.4.3 Mexico Diphtheria, Pertussis, and Tetanus Vaccine Consumption Volume from 2016 to 2021 Chapter 6 East Asia Diphtheria, Pertussis, and Tetanus Vaccine Market Analysis 6.1 East Asia Diphtheria, Pertussis, and Tetanus Vaccine Consumption and Value Analysis 6.1.1 East Asia Diphtheria, Pertussis, and Tetanus Vaccine Market Under COVID-19 6.2 East Asia Diphtheria, Pertussis, and Tetanus Vaccine Consumption Volume by Types 6.3 East Asia Diphtheria, Pertussis, and Tetanus Vaccine Consumption Structure by Application 6.4 East Asia Diphtheria, Pertussis, and Tetanus Vaccine Consumption by Top Countries 6.4.1 China Diphtheria, Pertussis, and Tetanus Vaccine Consumption Volume from 2016 to 2021 6.4.2 Japan Diphtheria, Pertussis, and Tetanus Vaccine Consumption Volume from 2016 to 2021 6.4.3 South Korea Diphtheria, Pertussis, and Tetanus Vaccine Consumption Volume from 2016 to 2021 Chapter 7 Europe Diphtheria, Pertussis, and Tetanus Vaccine Market Analysis 7.1 Europe Diphtheria, Pertussis, and Tetanus Vaccine Consumption and Value Analysis 7.1.1 Europe Diphtheria, Pertussis, and Tetanus Vaccine Market Under COVID-19 7.2 Europe Diphtheria, Pertussis, and Tetanus Vaccine Consumption Volume by Types 7.3 Europe Diphtheria, Pertussis, and Tetanus Vaccine Consumption Structure by Application 7.4 Europe Diphtheria, Pertussis, and Tetanus Vaccine Consumption by Top Countries 7.4.1 Germany Diphtheria, Pertussis, and Tetanus Vaccine Consumption Volume from 2016 to 2021 7.4.2 UK Diphtheria, Pertussis, and Tetanus Vaccine Consumption Volume from 2016 to 2021 7.4.3 France Diphtheria, Pertussis, and Tetanus Vaccine Consumption Volume from 2016 to 2021 7.4.4 Italy Diphtheria, Pertussis, and Tetanus Vaccine Consumption Volume from 2016 to 2021 7.4.5 Russia Diphtheria, Pertussis, and Tetanus Vaccine Consumption Volume from 2016 to 2021 7.4.6 Spain Diphtheria, Pertussis, and Tetanus Vaccine Consumption Volume from 2016 to 2021 7.4.7 Netherlands Diphtheria, Pertussis, and Tetanus Vaccine Consumption Volume from 2016 to 2021 7.4.8 Switzerland Diphtheria, Pertussis, and Tetanus Vaccine Consumption Volume from 2016 to 2021 7.4.9 Poland Diphtheria, Pertussis, and Tetanus Vaccine Consumption Volume from 2016 to 2021 Chapter 8 South Asia Diphtheria, Pertussis, and Tetanus Vaccine Market Analysis 8.1 South Asia Diphtheria, Pertussis, and Tetanus Vaccine Consumption and Value Analysis 8.1.1 South Asia Diphtheria, Pertussis, and Tetanus Vaccine Market Under COVID-19 8.2 South Asia Diphtheria, Pertussis, and Tetanus Vaccine Consumption Volume by Types 8.3 South Asia Diphtheria, Pertussis, and Tetanus Vaccine Consumption Structure by Application 8.4 South Asia Diphtheria, Pertussis, and Tetanus Vaccine Consumption by Top Countries 8.4.1 India Diphtheria, Pertussis, and Tetanus Vaccine Consumption Volume from 2016 to 2021 8.4.2 Pakistan Diphtheria, Pertussis, and Tetanus Vaccine Consumption Volume from 2016 to 2021 8.4.3 Bangladesh Diphtheria, Pertussis, and Tetanus Vaccine Consumption Volume from 2016 to 2021 Chapter 9 Southeast Asia Diphtheria, Pertussis, and Tetanus Vaccine Market Analysis 9.1 Southeast Asia Diphtheria, Pertussis, and Tetanus Vaccine Consumption and Value Analysis 9.1.1 Southeast Asia Diphtheria, Pertussis, and Tetanus Vaccine Market Under COVID-19 9.2 Southeast Asia Diphtheria, Pertussis, and Tetanus Vaccine Consumption Volume by Types 9.3 Southeast Asia Diphtheria, Pertussis, and Tetanus Vaccine Consumption Structure by Application 9.4 Southeast Asia Diphtheria, Pertussis, and Tetanus Vaccine Consumption by Top Countries 9.4.1 Indonesia Diphtheria, Pertussis, and Tetanus Vaccine Consumption Volume from 2016 to 2021 9.4.2 Thailand Diphtheria, Pertussis, and Tetanus Vaccine Consumption Volume from 2016 to 2021 9.4.3 Singapore Diphtheria, Pertussis, and Tetanus Vaccine Consumption Volume from 2016 to 2021 9.4.4 Malaysia Diphtheria, Pertussis, and Tetanus Vaccine Consumption Volume from 2016 to 2021 9.4.5 Philippines Diphtheria, Pertussis, and Tetanus Vaccine Consumption Volume from 2016 to 2021 9.4.6 Vietnam Diphtheria, Pertussis, and Tetanus Vaccine Consumption Volume from 2016 to 2021 9.4.7 Myanmar Diphtheria, Pertussis, and Tetanus Vaccine Consumption Volume from 2016 to 2021 Chapter 10 Middle East Diphtheria, Pertussis, and Tetanus Vaccine Market Analysis 10.1 Middle East Diphtheria, Pertussis, and Tetanus Vaccine Consumption and Value Analysis 10.1.1 Middle East Diphtheria, Pertussis, and Tetanus Vaccine Market Under COVID-19 10.2 Middle East Diphtheria, Pertussis, and Tetanus Vaccine Consumption Volume by Types 10.3 Middle East Diphtheria, Pertussis, and Tetanus Vaccine Consumption Structure by Application 10.4 Middle East Diphtheria, Pertussis, and Tetanus Vaccine Consumption by Top Countries 10.4.1 Turkey Diphtheria, Pertussis, and Tetanus Vaccine Consumption Volume from 2016 to 2021 10.4.2 Saudi Arabia Diphtheria, Pertussis, and Tetanus Vaccine Consumption Volume from 2016 to 2021 10.4.3 Iran Diphtheria, Pertussis, and Tetanus Vaccine Consumption Volume from 2016 to 2021 10.4.4 United Arab Emirates Diphtheria, Pertussis, and Tetanus Vaccine Consumption Volume from 2016 to 2021 10.4.5 Israel Diphtheria, Pertussis, and Tetanus Vaccine Consumption Volume from 2016 to 2021 10.4.6 Iraq Diphtheria, Pertussis, and Tetanus Vaccine Consumption Volume from 2016 to 2021 10.4.7 Qatar Diphtheria, Pertussis, and Tetanus Vaccine Consumption Volume from 2016 to 2021 10.4.8 Kuwait Diphtheria, Pertussis, and Tetanus Vaccine Consumption Volume from 2016 to 2021 10.4.9 Oman Diphtheria, Pertussis, and Tetanus Vaccine Consumption Volume from 2016 to 2021 Chapter 11 Africa Diphtheria, Pertussis, and Tetanus Vaccine Market Analysis 11.1 Africa Diphtheria, Pertussis, and Tetanus Vaccine Consumption and Value Analysis 11.1.1 Africa Diphtheria, Pertussis, and Tetanus Vaccine Market Under COVID-19 11.2 Africa Diphtheria, Pertussis, and Tetanus Vaccine Consumption Volume by Types 11.3 Africa Diphtheria, Pertussis, and Tetanus Vaccine Consumption Structure by Application 11.4 Africa Diphtheria, Pertussis, and Tetanus Vaccine Consumption by Top Countries 11.4.1 Nigeria Diphtheria, Pertussis, and Tetanus Vaccine Consumption Volume from 2016 to 2021 11.4.2 South Africa Diphtheria, Pertussis, and Tetanus Vaccine Consumption Volume from 2016 to 2021 11.4.3 Egypt Diphtheria, Pertussis, and Tetanus Vaccine Consumption Volume from 2016 to 2021 11.4.4 Algeria Diphtheria, Pertussis, and Tetanus Vaccine Consumption Volume from 2016 to 2021 11.4.5 Morocco Diphtheria, Pertussis, and Tetanus Vaccine Consumption Volume from 2016 to 2021 Chapter 12 Oceania Diphtheria, Pertussis, and Tetanus Vaccine Market Analysis 12.1 Oceania Diphtheria, Pertussis, and Tetanus Vaccine Consumption and Value Analysis 12.2 Oceania Diphtheria, Pertussis, and Tetanus Vaccine Consumption Volume by Types 12.3 Oceania Diphtheria, Pertussis, and Tetanus Vaccine Consumption Structure by Application 12.4 Oceania Diphtheria, Pertussis, and Tetanus Vaccine Consumption by Top Countries 12.4.1 Australia Diphtheria, Pertussis, and Tetanus Vaccine Consumption Volume from 2016 to 2021 12.4.2 New Zealand Diphtheria, Pertussis, and Tetanus Vaccine Consumption Volume from 2016 to 2021 Chapter 13 South America Diphtheria, Pertussis, and Tetanus Vaccine Market Analysis 13.1 South America Diphtheria, Pertussis, and Tetanus Vaccine Consumption and Value Analysis 13.1.1 South America Diphtheria, Pertussis, and Tetanus Vaccine Market Under COVID-19 13.2 South America Diphtheria, Pertussis, and Tetanus Vaccine Consumption Volume by Types 13.3 South America Diphtheria, Pertussis, and Tetanus Vaccine Consumption Structure by Application 13.4 South America Diphtheria, Pertussis, and Tetanus Vaccine Consumption Volume by Major Countries 13.4.1 Brazil Diphtheria, Pertussis, and Tetanus Vaccine Consumption Volume from 2016 to 2021 13.4.2 Argentina Diphtheria, Pertussis, and Tetanus Vaccine Consumption Volume from 2016 to 2021 13.4.3 Columbia Diphtheria, Pertussis, and Tetanus Vaccine Consumption Volume from 2016 to 2021 13.4.4 Chile Diphtheria, Pertussis, and Tetanus Vaccine Consumption Volume from 2016 to 2021 13.4.5 Venezuela Diphtheria, Pertussis, and Tetanus Vaccine Consumption Volume from 2016 to 2021 13.4.6 Peru Diphtheria, Pertussis, and Tetanus Vaccine Consumption Volume from 2016 to 2021 13.4.7 Puerto Rico Diphtheria, Pertussis, and Tetanus Vaccine Consumption Volume from 2016 to 2021 13.4.8 Ecuador Diphtheria, Pertussis, and Tetanus Vaccine Consumption Volume from 2016 to 2021 Chapter 14 Company Profiles and Key Figures in Diphtheria, Pertussis, and Tetanus Vaccine Business 14.1 Johnson & Johnson 14.1.1 Johnson & Johnson Company Profile 14.1.2 Johnson & Johnson Diphtheria, Pertussis, and Tetanus Vaccine Product Specification 14.1.3 Johnson & Johnson Diphtheria, Pertussis, and Tetanus Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.2 GlaxoSmithKline 14.2.1 GlaxoSmithKline Company Profile 14.2.2 GlaxoSmithKline Diphtheria, Pertussis, and Tetanus Vaccine Product Specification 14.2.3 GlaxoSmithKline Diphtheria, Pertussis, and Tetanus Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.3 Sanofi 14.3.1 Sanofi Company Profile 14.3.2 Sanofi Diphtheria, Pertussis, and Tetanus Vaccine Product Specification 14.3.3 Sanofi Diphtheria, Pertussis, and Tetanus Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.4 Lanzhou Institute of Biological 14.4.1 Lanzhou Institute of Biological Company Profile 14.4.2 Lanzhou Institute of Biological Diphtheria, Pertussis, and Tetanus Vaccine Product Specification 14.4.3 Lanzhou Institute of Biological Diphtheria, Pertussis, and Tetanus Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.5 Merck 14.5.1 Merck Company Profile 14.5.2 Merck Diphtheria, Pertussis, and Tetanus Vaccine Product Specification 14.5.3 Merck Diphtheria, Pertussis, and Tetanus Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.6 Novartis 14.6.1 Novartis Company Profile 14.6.2 Novartis Diphtheria, Pertussis, and Tetanus Vaccine Product Specification 14.6.3 Novartis Diphtheria, Pertussis, and Tetanus Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.7 AstraZeneca 14.7.1 AstraZeneca Company Profile 14.7.2 AstraZeneca Diphtheria, Pertussis, and Tetanus Vaccine Product Specification 14.7.3 AstraZeneca Diphtheria, Pertussis, and Tetanus Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.8 Emergent 14.8.1 Emergent Company Profile 14.8.2 Emergent Diphtheria, Pertussis, and Tetanus Vaccine Product Specification 14.8.3 Emergent Diphtheria, Pertussis, and Tetanus Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.9 Astellas 14.9.1 Astellas Company Profile 14.9.2 Astellas Diphtheria, Pertussis, and Tetanus Vaccine Product Specification 14.9.3 Astellas Diphtheria, Pertussis, and Tetanus Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021) Chapter 15 Global Diphtheria, Pertussis, and Tetanus Vaccine Market Forecast (2022-2027) 15.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Consumption Volume, Revenue and Price Forecast (2022-2027) 15.1.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Consumption Volume and Growth Rate Forecast (2022-2027) 15.1.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Value and Growth Rate Forecast (2022-2027) 15.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027) 15.2.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Consumption Volume and Growth Rate Forecast by Regions (2022-2027) 15.2.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Value and Growth Rate Forecast by Regions (2022-2027) 15.2.3 North America Diphtheria, Pertussis, and Tetanus Vaccine Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.2.4 East Asia Diphtheria, Pertussis, and Tetanus Vaccine Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.2.5 Europe Diphtheria, Pertussis, and Tetanus Vaccine Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.2.6 South Asia Diphtheria, Pertussis, and Tetanus Vaccine Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.2.7 Southeast Asia Diphtheria, Pertussis, and Tetanus Vaccine Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.2.8 Middle East Diphtheria, Pertussis, and Tetanus Vaccine Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.2.9 Africa Diphtheria, Pertussis, and Tetanus Vaccine Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.2.10 Oceania Diphtheria, Pertussis, and Tetanus Vaccine Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.2.11 South America Diphtheria, Pertussis, and Tetanus Vaccine Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.3 Global Diphtheria, Pertussis, and Tetanus Vaccine Consumption Volume, Revenue and Price Forecast by Type (2022-2027) 15.3.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Consumption Forecast by Type (2022-2027) 15.3.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue Forecast by Type (2022-2027) 15.3.3 Global Diphtheria, Pertussis, and Tetanus Vaccine Price Forecast by Type (2022-2027) 15.4 Global Diphtheria, Pertussis, and Tetanus Vaccine Consumption Volume Forecast by Application (2022-2027) 15.5 Diphtheria, Pertussis, and Tetanus Vaccine Market Forecast Under COVID-19 Chapter 16 Conclusions Research Methodology